Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease

Disease Markers

Volumn 31, Issue 5, 2011, Pages 295-301

  Huang, Yuli ^a   Hu, Yunzhao ^a   Mai, Weiyi ^b   Cai, Xiaoyan ^c   Song, Yuanbin ^b   Wu, Yanxian ^a   Dong, Yugang ^b   Huang, Huiling ^b   He, Zhongyun ^a   Li, Wensheng ^a   Yang, You ^a   Rao, Shaoqi ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SHUNDE HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

coronary artery disease; oxidized low density lipoprotein; Risk factors; young

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRAMINGHAM RISK SCORE; GROUPS BY AGE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

EID: 80955136833     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0832     Document Type: Article

References (31)

1. C. Fang, Y. Chen, R. Nie, G. Li, G. Xu, S. Zhou and J. Wang, Retrospective analysis of risk factors in young patients with coronary artery disease in Guangdong and Zhejiang, China, Acta Cardiol 64(2009), 195-199.
2. Cardiovascular risk factor profiles and angiography results in young patients], Acta Med. Austriaca 30 (2003), 72-75. (Pubitemid 37239094)
3. P. Greenland, L. LaBree, S.P. Azen, T.M. Doherty and R.C. Detrano, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals, JAMA 291 (2004), 210-215. (Pubitemid 38082815)
4. K. Eichler, M.A. Puhan, J. Steurer and L.M. Bachmann, Prediction of first coronary events with the Framingham score: A systematic review, Am.Heart J. 153 (2007), 722-731, 731.e1- e8.
5. S. Zarich, C. Luciano, J. Hulford and A. Abdullah, Prevalence of metabolic syndrome in young patients with acute MI: Does the Framingham Risk Score underestimate cardiovascular risk in this population, Diab Vasc Dis Res 3 (2006), 103-107. (Pubitemid 44638384)
6. I. Jialal, Evolving lipoprotein risk factors: Lipoprotein(a) and oxidized low-density lipoprotein, Clin Chem 44 (1998), 1827-1832. (Pubitemid 28368903)
7. S. Srimahachota, R. Wunsuwan, A. Siritantikorn, C. Boonla, S. Chaiwongkarjohn and P. Tosukhowong, Effects of lifestyle modification on oxidized LDL, reactive oxygen species production and endothelial cell viability in patients with coronary artery disease, Clin Biochem 43 (2010), 858-862.
8. T. Suzuki, H. Kohno, A. Hasegawa, S. Toshima, T. Amaki, M. Kurabayashi, R. Nagai, T. Suzuki, T. Amaki, R. Nagai, A. Hasegawa, S. Toshima, M.H. Kurabayashi, K. Shimada, H. Nakamura, T. Teramoto, H. Yamaguchi, S. Nishiyama, H. Takahashi, I. Michishita, Z. Sugano and K. Konoshi, Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease, Clin Biochem 35 (2002), 347-353. (Pubitemid 35247942)
9. H. Huang, W. Mai, D. Liu, Y. Hao, J. Tao and Y. Dong, The oxidation ratio of LDL: A predictor for coronary artery disease, Dis Markers 24 (2008), 341-349.
10. E.F. Schisterman and B.W. Whitcomb, Coronary age as a risk factor in the modified Framingham risk score, BMC Med Imaging 4 (2004), 1.
11. P.A. McCullough, S. Li, C.T. Jurkovitz, L. Stevens, A.J. Collins, S.C. Chen, K.C. Norris, S. McFarlane, B. Johnson, M.G. Shlipak, C.I. Obialo, W.W. Brown, J. Vassalotti, A.T. Whaley-Connell, R.M. Brenner and G.L. Bakris, Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-Term mortality, Am Heart J 156 (2008), 277-283.
12. A.F. Person and C. Patterson, Therapeutic options for premature coronary artery disease, Curr Treat Options Cardiovasc Med 10 (2008), 294-303.
13. Y. Furukawa, N. Ehara, R. Taniguchi, Y. Haruna, N. Ozasa, N. Saito, T. Doi, K. Hoshino, T. Tamura, S. Shizuta, M. Abe, M. Toma, T. Morimoto, S. Teramukai, M. Fukushima, T. Kita and T. Kimura, Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization, Circ J 73 (2009), 1459-1465.
14. P. Perrone-Filardi, S. Achenbach, S. Mohlenkamp, Z. Reiner, G. Sambuceti, J.D. Schuijf, Van Der Wall E, P.A. Kaufmann, J. Knuuti, S. Schroeder and M.J. Zellweger, Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: A position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology, Eur Heart J (2010). [Epub ahead of print, PMID: 20630895].
15. K. Nieman, Can CT angiography replace catheter coronary angiography, EuroIntervention 6(Suppl G) (2010), G65-G71.
16. P. Holvoet, J. Vanhaecke, S. Janssens, Van De Werf F and D. Collen, Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease, Circulation 98 (1998), 1487-1494. (Pubitemid 28481664)
17. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, D.W. Jones, B.J. Materson, S. Oparil, J.T.Wright, Jr. and E.J. Roccella, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report, JAMA 289 (2003), 2560-2572. (Pubitemid 37430158)
18. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults, Chinese guidelines on prevention and treatment of dyslipidemia in adults, Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007), 390-419.
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 26(Suppl 1) (2003), S5-S20.
20. J. Logue, L. Thompson, F. Romanes, D.C.Wilson, J, Thompson and N. Sattar, Management of obesity: Summary of SIGN guideline, BMJ 340 (2010), c154.
21. D. Sun, J. Cao, X. Liu, L. Yu, C. Yao, J. Li, D. Yu, J. Chen, J. Chen, X.Wu, J. Huang, J. He and D. Gu, Combined effects of smoking and systolic blood pressure on risk of coronary heart disease: A cohort study in Chinese women, J Womens Health (Larchmt) 19 (2010), 713-718.
22. C. Koz, O. Baysan, A. Hasimi, M. Cihan, M. Uzun, M. Yokusoglu, C. Sag and E. Isik, Conventional and non-conventional coronary risk factors in male premature coronary artery disease patients already having a low Framingham risk score, Acta Cardiol 63 (2008), 623-628.
23. F.S. Routledge, J.A. McFetridge-Durdle and C.R. Dean, Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women, Can J Cardiol 25 (2009), e157-e163.
24. K. Sachidanandam, S.C. Fagan and A. Ergul, Oxidative stress and cardiovascular disease: Antioxidants and unresolved issues, Cardiovasc Drug Rev 23 (2005), 115-132. (Pubitemid 41278971)
25. T. Pischon, C.J. Girman, F.M. Sacks, N. Rifai, M.J. Stampfer and E.B. Rimm, Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men, Circulation 112 (2005), 3375-3383. (Pubitemid 43739551)
26. T. Wu, W.C. Willett, N. Rifai, I. Shai, J.E. Manson and E.B. Rimm, Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women, J Am Coll Cardiol 48 (2006), 973-979. (Pubitemid 44292442)
27. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel and W. Koenig, Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-Aged men from the general population, Circulation 112 (2005), 651-657. (Pubitemid 41099043)
28. R.J. Bloomer, Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake, Nutr J 6 (2007), 39.
29. P.A. Sekher, K.R. Bruckdorfer and C.A. Rice-Evans, Smoking has no effect on the amino acid composition of apolipoprotein B100 of LDL while directly influencing the antioxidant status, Biochem Biophys Res Commun 292 (2002), 175-183. (Pubitemid 34687346)
30. A.W. Zieske, R.P. Tracy, C.A. McMahan, E.E. Herderick, S. Homma, G.T. Malcom, H.C. McGill, Jr. and J.P. Strong, Elevated serum C-reactive protein levels and advanced atherosclerosis in youth, Arterioscler Thromb Vasc Biol 25 (2005), 1237-1243. (Pubitemid 40776615)
31. T. Ueba, S. Nomura, T. Nishikawa, M. Kajiwara and K. Yamashita, Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese, Atherosclerosis 203 (2009), 243-248.